LOLLI, CRISTIAN
LOLLI, CRISTIAN
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Dottorandi
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number.
2010 Astolfi A; Nannini M; Pantaleo MA; Di Battista M; Heinrich MC; Santini D; Catena F; Corless CL; Maleddu A; Saponara M; Lolli C; Di Scioscio V; Formica S; Biasco G.
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours.
2014 Saponara M;Lolli C;Nannini M;DI Scioscio V;Serra C;Mandrioli A;Pallotti MC;Biasco G;Pantaleo MA
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA
2021 Conteduca V.; Brighi N.; Conteduca D.; Bleve S.; Gianni C.; Schepisi G.; Iaia M.L.; Gurioli G.; Lolli C.; De Giorgi U.
Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer
2017 Iacovelli, Roberto*; Cossu Rocca, Maria; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Santoni, Matteo; Mosca, Alessandra; Fornarini, Giuseppe; Massari, Francesco; Masini, Cristina; Bersanelli, Melissa; Biasco, Elisa; Lolli, Cristian; Guida, Annalisa; Berardi, Rossana; Terrone, Carlo; Pastorino, Alessandro; Ardizzoni, Andrea; Pinto, Carmine; Buti, Sebastiano; Nolè, Franco; Tortora, Giampaolo
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome
2021 Conteduca V.; Scarpi E.; Caroli P.; Lolli C.; Gurioli G.; Brighi N.; Poti G.; Farolfi A.; Altavilla A.; Schepisi G.; Matteucci F.; Paganelli G.; De Giorgi U.
CRITICAL ANALYSIS ON MANAGEMENT OF GIST PATIENTS WITH EVENT TREE MODEL
2008 Di Battista M; Pantaleo MA; Saponara M; Astorino M; Catena F; Lolli C; Di Scioscio V; Santini D; Castellucci P; Fusaroli P; Tomassetti P; Brandi G; Biasco G
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib.
2012 Pallotti MC;Pantaleo MA;Nannini M;Centofanti F;Fabbrizio B;Montanari M;Baraldi O;Saponara M;Lolli C;Mandrioli A;Biasco G;Prandini R
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib
2012 Pantaleo MA; Mandrioli A; Saponara M; Nannini M; Erente G; Lolli C; Biasco G.
Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors.
2014 M. A. Pantaleo;A. Astolfi;M. Urbini;F. Fuligni;M. Saponara;M. Nannini;C. Lolli;V. Indio;D. Santini;G. Ercolani;G. Brandi;A. D. Pinna;G. Biasco
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging
2021 Conteduca V.; Poti G.; Caroli P.; Russi S.; Brighi N.; Lolli C.; Schepisi G.; Romeo A.; Matteucci F.; Paganelli G.; Marchetti P.; De Giorgi U.
Follow-up del cancro del pancreas esocrino
2015 Agostini Valentina, Barbera Maria Aurelia, Brighi Nicole, Casolino Raffaella, Corbelli Jody, Dall'Olio Filippo Gustavo, De Lorenzo Stefania, De Rosa Francesco, Degli Esposti Claudio, Di Girolamo Stefania, Di Marco Mariacristina, Di Tullio Piergiorgio, Frega Giorgio, Freier Eva, Garajova Ingrid, Gatto Lidia, Grassi Elisa, Katsinas Giovanna, Lolli Cristian, Macchini Marina, Maleddu Alessandra, Mandrioli Anna, Minchillo Santino, Nannini Margherita, Palloni Andrea, Pallotti Maria Caterina, Pantaleo Maria Abbondanza, Paragona Marco, Pini Sara, Saponara Maristella, Vecchiarelli Silvia, Venturi Michela, Verlicchi Lea, Zucchini Giorgia
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations
2015 Maria A. Pantaleo;Cristian Lolli;Margherita Nannini;Annalisa Astolfi;Valentina Indio;Maristella Saponara;Milena Urbini;Stefano La Rovere;Antony Gill;David Goldstein;Claudio Ceccarelli;Donatella Santini;Giulio Rossi;Michelangelo Fiorentino;Valerio Di Scioscio;Pietro Fusaroli;Anna Mandrioli;Lidia Gatto;Fausto Catena;Umberto Basso;Giorgio Ercolani;Antonio Daniele Pinna;Guido Biasco
Immune modulation in prostate cancer patients treated with androgen receptor (Ar)-targeted therapy
2020 Conteduca V.; Caffo O.; Scarpi E.; Sepe P.; Galli L.; Fratino L.; Maines F.; Chiuri V.E.; Santoni M.; Zanardi E.; Massari F.; Toma I.; Lolli C.; Schepisi G.; Sbrana A.; Kinspergher S.; Cursano M.C.; Casadei C.; Modonesi C.; Santini D.; Procopio G.; De Giorgi U.
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy
2021 Schepisi G.; Casadei C.; Toma I.; Poti G.; Iaia M.L.; Farolfi A.; Conteduca V.; Lolli C.; Ravaglia G.; Brighi N.; Altavilla A.; Martinelli G.; De Giorgi U.
INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study
2018 Bersanelli M.; Giannarelli D.; Castrignano P.; Fornarini G.; Panni S.; Mazzoni F.; Tiseo M.; Rossetti S.; Gambale E.; Rossi E.; Papa A.; Cortellini A.; Lolli C.; Ratta R.; Michiara M.; Milella M.; Luca E.D.; Soraru M.; Mucciarini C.; Atzori F.; Banna G.L.; Torre L.L.; Vitale M.G.; Massari F.; Rebuzzi S.E.; Facchini G.; Schinzari G.; Tomao S.; Bui S.; Vaccaro V.; Procopio G.; Giorgi U.D.; Santoni M.; Ficorella C.; Sabbatini R.; Maestri A.; Natoli C.; Tursi M.D.; Maio M.D.; Rapacchi E.; Pireddu A.; Sava T.; Lipari H.; Comito F.; Verzoni E.; Leonardi F.; Buti S.
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target.
2009 Pantaleo MA; Astolfi A; Di Battista M; Heinrich MC; Paterini P; Scotlandi K; Santini D; Catena F; Manara MC; Nannini M; Maleddu A; Saponara M; Lolli C; Formica S; Biasco G.
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)
2014 Margherita Nannini;Annalisa Astolfi;Milena Urbini;Valentina Indio;Donatella Santini;Michael C Heinrich;Christopher L Corless;Claudio Ceccarelli;Maristella Saponara;Anna Mandrioli;Cristian Lolli;Giorgio Ercolani;Giovanni Brandi;Guido Biasco;Maria A Pantaleo
Integrative analysis of gene expression profiling and high-resolution genomic copy number in gastrointestinal stromal tumor (GIST).
2009 M. Nannini; A. Astolfi; M. A. Pantaleo; M. Di Battista; S. Formica; D. Santini; M. Saponara; A. Maleddu; C. Lolli; G. Martinelli; G. Biasco
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up.
2012 Nannini M; Biasco G; Pallotti MC; Di Battista M; Santini D; Paterini P; Maleddu A; Mandrioli A; Lolli C; Saponara M; Di Scioscio V; Zompatori M; Catena F; Fusaroli P; Dei Tos AP; Pantaleo MA.
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone
2017 Conteduca V.; Caffo O.; Lolli C.; Aieta M.; Scarpi E.; Bianchi E.; Maines F.; Schepisi G.; Salvi S.; Massari F.; Carrozza F.; Veccia A.; Chiuri V.E.; Campadelli E.; Facchini G.; De Giorgi U.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. | Astolfi A; Nannini M; Pantaleo MA; Di Battista M; Heinrich MC; Santini D; Catena F; Corless CL; M...aleddu A; Saponara M; Lolli C; Di Scioscio V; Formica S; Biasco G. | 2010-01-01 | LABORATORY INVESTIGATION | - | 1.01 Articolo in rivista | - |
| Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. | Saponara M;Lolli C;Nannini M;DI Scioscio V;Serra C;Mandrioli A;Pallotti MC;Biasco G;Pantaleo MA | 2014-01-01 | ONCOLOGY LETTERS | - | 1.01 Articolo in rivista | - |
| An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA | Conteduca V.; Brighi N.; Conteduca D.; Bleve S.; Gianni C.; Schepisi G.; Iaia M.L.; Gurioli G.; L...olli C.; De Giorgi U. | 2021-01-01 | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | - | 1.01 Articolo in rivista | - |
| Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer | Iacovelli, Roberto*; Cossu Rocca, Maria; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Santoni..., Matteo; Mosca, Alessandra; Fornarini, Giuseppe; Massari, Francesco; Masini, Cristina; Bersanelli, Melissa; Biasco, Elisa; Lolli, Cristian; Guida, Annalisa; Berardi, Rossana; Terrone, Carlo; Pastorino, Alessandro; Ardizzoni, Andrea; Pinto, Carmine; Buti, Sebastiano; Nolè, Franco; Tortora, Giampaolo | 2017-01-01 | UROLOGIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome | Conteduca V.; Scarpi E.; Caroli P.; Lolli C.; Gurioli G.; Brighi N.; Poti G.; Farolfi A.; Altavil...la A.; Schepisi G.; Matteucci F.; Paganelli G.; De Giorgi U. | 2021-01-01 | MOLECULAR ONCOLOGY | - | 1.01 Articolo in rivista | Molecular Oncology - 2021 - Conteduca - Combining liquid biopsy and functional imaging analysis in metastatic.pdf; Supplementary materials.zip |
| CRITICAL ANALYSIS ON MANAGEMENT OF GIST PATIENTS WITH EVENT TREE MODEL | Di Battista M; Pantaleo MA; Saponara M; Astorino M; Catena F; Lolli C; Di Scioscio V; Santini D; ...Castellucci P; Fusaroli P; Tomassetti P; Brandi G; Biasco G | 2008-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
| Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. | Pallotti MC;Pantaleo MA;Nannini M;Centofanti F;Fabbrizio B;Montanari M;Baraldi O;Saponara M;Lolli... C;Mandrioli A;Biasco G;Prandini R | 2012-01-01 | CASE REPORTS IN ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib | Pantaleo MA; Mandrioli A; Saponara M; Nannini M; Erente G; Lolli C; Biasco G. | 2012-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | development.pdf |
| Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors. | M. A. Pantaleo;A. Astolfi;M. Urbini;F. Fuligni;M. Saponara;M. Nannini;C. Lolli;V. Indio;D. Santin...i;G. Ercolani;G. Brandi;A. D. Pinna;G. Biasco | 2014-01-01 | CLINICAL SARCOMA RESEARCH | - | 1.01 Articolo in rivista | - |
| Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging | Conteduca V.; Poti G.; Caroli P.; Russi S.; Brighi N.; Lolli C.; Schepisi G.; Romeo A.; Matteucci... F.; Paganelli G.; Marchetti P.; De Giorgi U. | 2021-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 1758835920987654.pdf |
| Follow-up del cancro del pancreas esocrino | Agostini Valentina, Barbera Maria Aurelia, Brighi Nicole, Casolino Raffaella, Corbelli Jody, Dall...'Olio Filippo Gustavo, De Lorenzo Stefania, De Rosa Francesco, Degli Esposti Claudio, Di Girolamo Stefania, Di Marco Mariacristina, Di Tullio Piergiorgio, Frega Giorgio, Freier Eva, Garajova Ingrid, Gatto Lidia, Grassi Elisa, Katsinas Giovanna, Lolli Cristian, Macchini Marina, Maleddu Alessandra, Mandrioli Anna, Minchillo Santino, Nannini Margherita, Palloni Andrea, Pallotti Maria Caterina, Pantaleo Maria Abbondanza, Paragona Marco, Pini Sara, Saponara Maristella, Vecchiarelli Silvia, Venturi Michela, Verlicchi Lea, Zucchini Giorgia | 2015-01-01 | - | Bologna University Press | 2.01 Capitolo / saggio in libro | - |
| Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations | Maria A. Pantaleo;Cristian Lolli;Margherita Nannini;Annalisa Astolfi;Valentina Indio;Maristella S...aponara;Milena Urbini;Stefano La Rovere;Antony Gill;David Goldstein;Claudio Ceccarelli;Donatella Santini;Giulio Rossi;Michelangelo Fiorentino;Valerio Di Scioscio;Pietro Fusaroli;Anna Mandrioli;Lidia Gatto;Fausto Catena;Umberto Basso;Giorgio Ercolani;Antonio Daniele Pinna;Guido Biasco | 2015-01-01 | GENETICS IN MEDICINE | - | 1.01 Articolo in rivista | gim2014115a.pdf |
| Immune modulation in prostate cancer patients treated with androgen receptor (Ar)-targeted therapy | Conteduca V.; Caffo O.; Scarpi E.; Sepe P.; Galli L.; Fratino L.; Maines F.; Chiuri V.E.; Santoni... M.; Zanardi E.; Massari F.; Toma I.; Lolli C.; Schepisi G.; Sbrana A.; Kinspergher S.; Cursano M.C.; Casadei C.; Modonesi C.; Santini D.; Procopio G.; De Giorgi U. | 2020-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | Journal Clinical Medicine [Conteduca].pdf |
| Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy | Schepisi G.; Casadei C.; Toma I.; Poti G.; Iaia M.L.; Farolfi A.; Conteduca V.; Lolli C.; Ravagli...a G.; Brighi N.; Altavilla A.; Martinelli G.; De Giorgi U. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-00840-v2.pdf |
| INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study | Bersanelli M.; Giannarelli D.; Castrignano P.; Fornarini G.; Panni S.; Mazzoni F.; Tiseo M.; Ross...etti S.; Gambale E.; Rossi E.; Papa A.; Cortellini A.; Lolli C.; Ratta R.; Michiara M.; Milella M.; Luca E.D.; Soraru M.; Mucciarini C.; Atzori F.; Banna G.L.; Torre L.L.; Vitale M.G.; Massari F.; Rebuzzi S.E.; Facchini G.; Schinzari G.; Tomao S.; Bui S.; Vaccaro V.; Procopio G.; Giorgi U.D.; Santoni M.; Ficorella C.; Sabbatini R.; Maestri A.; Natoli C.; Tursi M.D.; Maio M.D.; Rapacchi E.; Pireddu A.; Sava T.; Lipari H.; Comito F.; Verzoni E.; Leonardi F.; Buti S. | 2018-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. | Pantaleo MA; Astolfi A; Di Battista M; Heinrich MC; Paterini P; Scotlandi K; Santini D; Catena F;... Manara MC; Nannini M; Maleddu A; Saponara M; Lolli C; Formica S; Biasco G. | 2009-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) | Margherita Nannini;Annalisa Astolfi;Milena Urbini;Valentina Indio;Donatella Santini;Michael C Hei...nrich;Christopher L Corless;Claudio Ceccarelli;Maristella Saponara;Anna Mandrioli;Cristian Lolli;Giorgio Ercolani;Giovanni Brandi;Guido Biasco;Maria A Pantaleo | 2014-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | 1471-2407-14-685.pdf |
| Integrative analysis of gene expression profiling and high-resolution genomic copy number in gastrointestinal stromal tumor (GIST). | M. Nannini; A. Astolfi; M. A. Pantaleo; M. Di Battista; S. Formica; D. Santini; M. Saponara; A. M...aleddu; C. Lolli; G. Martinelli; G. Biasco | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. | Nannini M; Biasco G; Pallotti MC; Di Battista M; Santini D; Paterini P; Maleddu A; Mandrioli A; L...olli C; Saponara M; Di Scioscio V; Zompatori M; Catena F; Fusaroli P; Dei Tos AP; Pantaleo MA. | 2012-01-01 | MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone | Conteduca V.; Caffo O.; Lolli C.; Aieta M.; Scarpi E.; Bianchi E.; Maines F.; Schepisi G.; Salvi ...S.; Massari F.; Carrozza F.; Veccia A.; Chiuri V.E.; Campadelli E.; Facchini G.; De Giorgi U. | 2017-01-01 | THE PROSTATE | - | 1.01 Articolo in rivista | - |